Ingevity Corporation (NGVT) Stock Price & How to Invest

Ingevity Corporation is a South Carolina-based specialty chemicals maker that was spun off from WestRock in 2016. It operates through three segments: Performance Materials, which engineers activated carbon for automotive gasoline vapor emission control canisters (where Ingevity holds an estimated 80 to 85 percent global share and earns EBITDA margins above 50 percent); Performance Chemicals, centered on pavement and road technologies plus industrial specialties; and Advanced Polymer Technologies, which makes caprolactone-based specialty polymers for coatings, adhesives, elastomers, and medical uses.

The investment picture in 2026 is dominated by a portfolio cleanup. Ingevity sold its North Charleston crude tall oil refinery and most of its Industrial Specialties line for about $110 million, and set out plans to divest Advanced Polymer Technologies and its Road Markings business as well. In late September 2026 CEO David Li said two of the three planned divestitures were complete and the Advanced Polymer Technologies sale was in advanced stages. The goal is a smaller, higher-margin company built around the emissions-carbon franchise and pavement technologies, funding debt reduction along the way. The long-term question is how durable the automotive carbon cash engine remains as electric vehicles, which have no gasoline vapor to capture, gradually take share. Results so far in 2026 have beaten expectations: second-quarter revenue was about $314 million, down roughly 5% year over year as divested lines dropped out, but adjusted EPS of $1.74 came in well above the $1.33 consensus. As of October 16, 2026 the stock closed near $70.75, up about 18% year to date and 28% over a year.

The largest structural risk is electric vehicle adoption, since EVs eliminate the gasoline vapor demand that drives Ingevity's most profitable business, making Performance Materials concentration a double-edged sword. Trailing earnings have been distorted by impairments and charges (GAAP net income over the last twelve months is only about $25 million, a trailing P/E near 101), and the company carries total debt of about $1.24 billion. A pre-tax litigation settlement with BASF (about $113 million) weighs on near-term cash. Pavement and industrial demand are cyclical and sensitive to construction activity and input costs, and the pending Advanced Polymer Technologies sale introduces execution and valuation uncertainty. Revenue is shrinking as businesses are sold, down about 5% year over year in the June 2026 quarter, so the story leans on margins rather than growth. Chinese and other low-cost activated carbon producers pressure parts of the portfolio.

3 analysts publish price targets on NGVT, averaging $89.00 against a $69.82 price as of October 2026, or +27.5%. The published targets run from $85.00 to $92.00, a narrow spread, and the ratings split 3 buy, 0 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full NGVT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Ingevity Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Dominant, high-margin emissions carbon. Performance Materials supplies activated carbon for gasoline vapor emission control systems, where Ingevity holds roughly 80 to 85 percent global share and margins above 50 percent. The most optimistic published target, $92.00, assumes this works close to its best case.

The case against. The largest structural risk is electric vehicle adoption, since EVs eliminate the gasoline vapor demand that drives Ingevity's most profitable business, making Performance Materials concentration a double-edged sword. The most pessimistic target, $85.00, is roughly what NGVT is worth if this bites instead.

Read the full bull and bear case on NGVT, including what would have to change to break either one. Walnut is not an investment adviser.

No. Ingevity Corporation (NGVT) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Ingevity Corporation's investor relations page or your broker.

• Revenue (TTM): ~$1.16B
• Q2 2026 revenue growth: ~-5% year over year
• Operating margin (TTM): ~30%
• EPS (Q2 2026 adj. vs estimate): $1.74 vs ~$1.33
• P/E (trailing / forward): ~101 / ~11.8
• Market cap: ~$2.4B
• Total debt: ~$1.24B; leverage ~2.5x per management

Trailing GAAP earnings are depressed by prior impairments and charges, so the trailing P/E near 101 says little, and the market leans on forward and adjusted metrics: analysts expect about $5.24 of EPS for 2026 and $6.01 for 2027, putting the forward P/E near 11.8 at the October 16, 2026 close of about $70.75. Third-quarter results are due November 4, 2026, with consensus near $1.59 of EPS on about $305 million of revenue. The story is more about margin quality, deleveraging, and portfolio simplification than top-line growth.

Other names that sit close to NGVT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get NGVT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so NGVT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NGVT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

NGVT pairs a high-margin, dominant emissions-carbon franchise with a leaner, deleveraging portfolio, offset by cyclical pavement demand and the slow structural threat of EV adoption. It beat EPS estimates in each of the first two quarters of 2026, trades near 12 times forward earnings, and reports third-quarter results on November 4, 2026.

Whether NGVT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NGVT a buy or a sell?, and where the stock could go from here in the NGVT stock forecast.

For income investors, whether NGVT pays a dividend and how the payout looks is covered in does NGVT pay a dividend? And to weigh NGVT against a peer, read the full side-by-side comparisons: NGVT vs WDFC and NGVT vs SOLS.